Please check the following:
- {{x.value}}
FREE membership
FREE membership
Join Intelligent Investor today
{{ twilioFailed ? 'SMS Code Failed to Send…' : 'Enter verification code' }}
Please enter the 5 digit verification code sent to "{{user.DayPhone}}" Change number
We cannot send you a verification code via SMS to "{{user.DayPhone}}" Change number
{{ completedStep1 ? 'Authentication & Security' : content.trialHeading.replace('{0}', user.FirstName) }}
Please enter your mobile number and press send to receive a text message with a verification code.
{{ content.upgradeHeading.replace('{0}', user.FirstName) }}
The email address you entered is registered with InvestSMART
Please login to continue
Thank you
We have sent you an email with the details of your registration.
Purchase order
Sign up
Log in
Looks you are already a member. Please enter your password to proceed
{{ upgradeCTAText }}
Updating information
Please wait ...
Your membership to InvestSMART Group recently failed to renew.
Please make sure your payment details are up to date to continue your membership.
Having trouble renewing?
Please contact Member Services on support@investsmart.com.au or 1300 880 160
You've recently updated your payment details.
It may take a few minutes to update your subscription details, during this time you will not be able to view locked content.
If you are still having trouble viewing content after 10 minutes, try logging out of your account and logging back in.
Still having trouble viewing content?
Please contact Member Services on support@investsmart.com.au or 1300 880 160
Please click on the ACTIVATE button to activate your Intelligent Investor 15-day free trial
Please click on the ACTIVATE button to finalise your membership
Log in
Upgrade Today
Unsuccessful registration
Registration for this event is available only to Eureka Report members. View our membership page for more information.
Registration for this event is available only to Intelligent Investor members. View our membership page for more information.
{{eventFunction.Name}}
{{eventFunction.EventTypeName}}
{{eventFunction.StartDate}}
{{eventFunction.EventTimings}}
{{eventFunction.VenueName}}
{{ t.Cost === 0 ? "FREE" : "$" + t.Cost.toFixed(2) }}
Quantity *
- You are already registered for this event.
- This event is already full.
- Please select a quantity for at least one ticket.
- {{ i }}
Forgotten password
Please enter your email address below to request a new password
Congratulations!
You now have free access to InvestSMART, we look forward to helping you on your financial journey.
You now have access to Free Eureka Report Insights, We look forward to helping you on your financial journey.
You now have access to Intelligent Investor Free Insights. We look forward to helping you build a market beating stock portfolio.
Looking for more…
Intelligent Investor Membership
15-day Free Trial
- Indepth analysis of ASX listed shares
- BUY, Hold and Sell Recommendations
- Ideas Lab
- Special Reports
No thanks
Looking for more…
Eureka Report Membership
15-day Free Trial
- Alan Kohler’s Weekend Briefing
- Interviews with CEO’s & top influencers
- Money Cafe and Talking Finance
- Super Advice and Q&A with Ask Alan
No thanks
Estia Health Limited (ASX: EHE) - Share Price and Research
DELISTED - Current share price for EHE : $3.080
EHE General Information +
| ASX Code | EHE |
| Website | N/A |
| Industry/Sector | Health Care Facilities |
| Market Cap ($M) | n/a |
| EHE Share Price | $3.080 |
| Day High | $3.080 |
| Day Low | $3.070 |
| Last Close | $3.080 |
| EHE Share Price Movement | - ( No change ) |
Prices as at 16:35, 19 Dec 2023
+Security prices are delayed by at least 20 minutes and are indicative only.
EHE Related Research
Estia Health Limited (EHE) Upcoming Dividends & Yields
| Distribution Type | Dividend | Franking | Ex-dividend date | Payment date | Current Price+ | Price 7D Avg | Dividend Yield |
|---|---|---|---|---|---|---|---|
| HFResult | 12¢ | 100% | 25 Aug 2023 | 15 Sep 2023 | $3.080 | $3.080 | 5.10% |
| Result | 3.7¢ | 100% | 24 Feb 2023 | 17 Mar 2023 | $3.080 | $3.080 | 5.10% |
| Result | 2.35¢ | 100% | 25 Feb 2022 | 18 Mar 2022 | $3.080 | $3.080 | 5.10% |
See all dividends from Estia Health Limited (EHE) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.
Estia Health Limited (EHE) Recent ASX Announcements
| Headline | Annoucement date/time+ | Price at announcement+ | Current price+ | Price 7D Avg | Gain/Loss |
|---|---|---|---|---|---|
| Removal from Official List | 18 Dec 2023 8:38AM | $3.080 | $3.080 | $3.080 | fallen by 0% |
| Final Director's Interest Notice - Mr Paul Foster | 15 Dec 2023 4:43PM | $3.080 | $3.080 | $3.080 | fallen by 0% |
| Final Director's Interest Notice - Ms Karen Penrose | 15 Dec 2023 4:43PM | $3.080 | $3.080 | $3.080 | fallen by 0% |
- + Company announcements and prices are delayed by at least 20 minutes. Prices are indicative only.
See all ASX announcements from Estia Health Limited (EHE) or use our ASX Announcements tool to search for announcements across all ASX-listed securities.
EHE Directors
| Name | Position | Start Date |
|---|---|---|
| Mr Sean Bilton | Chief Executive Officer, Managing Director | 11 Jul 2022 |
| Ms Norah Kathleen Barlow | Non-Executive Director | 17 Nov 2014 |
| Professor Simon Willcock | Non-Executive Director | 1 Sep 2022 |
Estia Health Limited (EHE) Changes in Directors' Interest & Trades
| Date of change | Director | Buy/Sell | Security Type | Qty | Trade Price | Value |
|---|---|---|---|---|---|---|
| 2 Mar 2023 | PENROSE, Karen | Buy | Indirect Shares | 7,238 | $2.070 | $14,982.660 |
| 24 Feb 2023 | WEISS, Gary | Buy | Indirect Shares | 25,000 | $2.070 | $51,750.000 |
| 17 Nov 2022 | BILTON, Sean | Buy | Direct Shares | 48,623 | $2.180 | $105,998.140 |
See all changes in directors' interest & trades for Estia Health Limited (EHE) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.
EHE Management
| Name | Position |
|---|---|
| Steve Lemlin | Chief Financial Officer |
| Damian Hiser | Chief Operating Officer |
| Leanne Ralph | Company Secretary |
EHE Substantial Shareholders
Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in -- (EHE). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.
| Holding | Name |
|---|---|
| 18,232,894 (6.97%) | Citigroup Global Markets Australia Pty Limited |
| 16,799,727 (6.46%) | Milford Asset Management Limited |
| 14,488,136 (5.61%) | UBS Group AG and its related bodies corporate |
EHE Calendar of Events
| Date | Event |
|---|---|
| 11 October 2024 | Report (Annual) |
| 20 August 2024 | Report (Prelim) |
FAQs about Estia Health Limited (EHE)
What is the current share price of Estia Health Limited (EHE)?
Estia Health Limited's (EHE) current share price is $3.08. This constitutes a price movement of 0% when compared to the share price 7 days ago and is -1.60% below EHE's 12-month high of $3.13 per share. Prices are delayed by at least 20 minutes.
What is the share price movement for Estia Health Limited (EHE)?
Relative to the previous close share price of $3.08, Estia Health Limited's (EHE) current share price of $3.08 constitutes a movement of or 0%. Estia Health Limited's (EHE) share price movement is 0% when compared to 7 days ago and is -1.60% below EHE's 52-week high of $3.13.
What is the 52-week high share price for Estia Health Limited (EHE)?
Estia Health Limited's (EHE) 52-week high is $3.13 which was reached on 14 Aug 2023. Relative to this, EHE's current share price of $3.08 constitutes a -$0.05 or -1.60% drop since that high of $3.13 per EHE share.
What is the 52-week low share price for Estia Health Limited (EHE)?
Estia Health Limited's (EHE) 52-week low is $2.46 which was reached on 10 May 2023. Relative to this, EHE's current share price of $3.08 constitutes a $0.62 or 25.20% gain since that low of $2.46 per EHE share.
What is the daily average trading volume for Estia Health Limited (EHE)?
Over the last 12 months, Estia Health Limited (EHE) has a daily average trading volume of 1,210,522 EHE shares per day.
What is the dividend yield for Estia Health Limited (EHE)?
Estia Health Limited (EHE) has a current dividend yield of n/a this year. Last year's dividend yield was n/a. The dividend yield for EHE is a ratio that tells you the percentage of Estia Health Limited's (EHE) share price that it pays out in dividends each year.
What was Estia Health Limited (EHE) last dividend payment?
Estia Health Limited (EHE) last dividend payment was $0.12 per share and was paid on 15 Sep 2023. This last EHE dividend included 100% franking.
When does Estia Health Limited (EHE) release its next Annual Report?
Estia Health Limited (EHE) will release its next Annual Report on 11 October 2024. Estia Health Limited's (EHE) last annual report was released on 13 Oct 2023. Click here to view Estia Health Limited's (EHE) last annual report.
In which sector is Estia Health Limited (EHE) classified?
Estia Health Limited (EHE) is classified as Health Care. Other companies in this sector include CSL Limited (CSL), ResMed Inc. (RMD), Cochlear Limited (COH), and Fisher & Paykel Healthcare Corporation Limited (FPH).
DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.
Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate,
complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892)
and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and,
if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest.
No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser.
Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.
What our members say about us
Proudly
We're here to help
Call 1300 880 160
Start a chat
Schedule a call
